Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
about
Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic ReviewCeftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis.Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid and Mitral Valve Methicillin-Resistant Staphylococcus aureus Endocarditis.Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.High incidence of discontinuations due to adverse events in patients treated with ceftaroline.Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.When sepsis persists: a review of MRSA bacteraemia salvage therapy.Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.Outcomes of vancomycin plus a β-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
P2860
Q33879066-A19018AA-D0B0-45F9-9428-AC937D8F2700Q34801960-25205212-4DCF-47F2-BD30-9A030FC3DA7AQ35542062-DE11E4F4-58C4-4827-9081-B7DF7698EF69Q36093730-25D3D429-5320-4ABC-BBD5-615BB82AFB12Q37382998-287EDD11-9050-47A0-9880-44DD6FF63865Q37613052-9070338F-60F3-4C7C-95BA-CAB05B59B98AQ38210123-804A1E29-F6F0-44AE-A93E-6395ADCC7551Q38462842-F4695579-0639-45D4-AE7D-4715BD4F2BF0Q38632488-8369AB1E-6875-4F66-8C75-9FA09E44A6E2Q38926404-2EBA9BBC-43DF-43F3-84B4-55C3C21A3710Q40709730-36C3663C-6AF3-405D-8921-FAB519CCF923Q41378759-89E8187C-6E27-47D3-B549-E734204248A6Q41657172-62522F1F-0E4F-4EAC-AE22-656EA5DCA542Q46916150-978BA180-8529-42CC-8C12-128C312C1E58Q47634145-5EB8883D-8A40-40BE-B4C7-61B035A19B5F
P2860
Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ceftaroline for meticillin-res ...... and review of the literature.
@en
type
label
Ceftaroline for meticillin-res ...... and review of the literature.
@en
prefLabel
Ceftaroline for meticillin-res ...... and review of the literature.
@en
P1476
Ceftaroline for meticillin-res ...... s and review of the literature
@en
P2093
Craig M Pleiman
P304
P356
10.1016/J.IJANTIMICAG.2013.07.005
P577
2013-08-11T00:00:00Z